Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around
Hologic and Agfa have finalized an agreement under which Hologic will manufacture a digital mammography system to be private-labeled and distributed by Agfa in certain international markets. The system, which Agfa will call Embrace, will be built around Hologic's flat-panel amorphous selenium technology but will include Agfa image processing and information technology. The Joint Development and OEM Purchase Agreement is an outgrowth of a Letter of Intent signed by the two companies in April 2002.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.
Contrast-Enhanced Mammography Study Reveals 24 Percent Lower Sensitivity with Moderate/Marked BPE
April 30th 2025In comparison to minimal or mild background parenchymal enhancement on contrast-enhanced mammography (CEM), researchers found that moderate or marked BPE was associated with a 12 percent lower AUC for breast cancer detection.